BLUEBIRD BIO
bluebird bio is a clinical-stage biotechnology company that develops gene therapies for severe genetic and rare diseases. The company's gene therapy procedures aim to genetically modify a patient's cells to fundamentally correct or address the genetic basis underlying a disease. Bluebird's revenue is derived from collaboration arrangements, research fees, license fees, and grant revenue. The company works with industry peers, strategic partners, and nonprofit organizations for the development and commercialization of its product candidates.
BLUEBIRD BIO
Industry:
Biotechnology Genetics Health Diagnostics Pharmaceutical
Founded:
1993-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.bluebirdbio.com
Total Employee:
501+
Status:
Active
Contact:
339-499-9300
Total Funding:
484 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Google Tag Manager Microsoft Exchange Online Amazon Office 365 Mail IPv6
Similar Organizations
Rapid Diagnostek
Rapid Diagnostek develops biosensor-based diagnostic tests for the detection of proteins, bacteria and viruses contained in liquid samples.
Radius Health
Radius Health develops drug therapies for osteoporosis and women’s health.
Nevro
Nevro provides pain relief solutions for patients suffering from low back pain and other types of chronic pain.
Navitor Pharmaceuticals
Navitor Pharma is a developer of novel medicines designed to target specific nutrient-sensing proteins to treat diseases.
NeoGenomics
NeoGenomics is a cancer reference laboratory that provides cancer testing and partnership programs to pathologists and oncologists.
Natera
Natera specializes in cell-free DNA testing to elevate the science and utility of prenatal testing.
Volta Labs
Volta Labs develops scalable automation for genetic engineering.
Verve Therapeutics
Verve Therapeutics is a genetic medicine firm that is developing treatments for cardiovascular disease.
MultiplexDX Inc.
Developing products for precision medicine: affordable, reliable, specific, quantifiable, and accurate precision diagnostic technology.
MitrAssist
MitrAssist offers a minimally invasive approach to mitral regurgitation treatment.
Marinus Pharmaceuticals
Marinus Pharmaceuticals reformulates, develops, and commercializes drugs to treat neurological, psychiatric, and pain disorders.
Lentigen
Lentigen Corporation is engaged in the development and commercialization of gene delivery technologies for human diseases.
Avidity Biosciences
Avidity Biosciences is a biotechnology company that develops oligonucleotide-based therapies for its patients.
Aushon BioSystems
Aushon BioSystems provides robust protein biomarker assay development, detection and analysis through multiplex immunoassay platform.
Agendia
Agendia provides molecular diagnostics and personalized treatment plans for cancer patients.
Abeona Therapeutics
Abeona Therapeutics develops gene therapy-based potential cures for Sanfilippo syndrome types A and B.
Advaxis
Advaxis is a developer of multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer.
Allcyte
Allcyte is a biotech start-up focused on precision medicine and drug development in a patient-centric way using high-content imaging and AI
Anjarium Biosciences
Anjarium is focused on creating new class of non-viral gene therapies to deliver predictable ,inclusionary ways to tackle genetic diseases.
Applied BioCode
Applied BioCode commercializes a multiplexing system used in clinical testing, life science research, medicine, and the AgBio field.
ARCH Venture Partners
ARCH is a venture firm that focuses on life science discoveries to prevent, detect, and cure disease.
Agilent Technologies
Agilent Technologies addresses the scientific and laboratory management needs of analytical scientists and clinical researchers.
Exosome Diagnostics
Exosome Diagnostics develops and commercializes blood-based cancer molecular diagnostics for patient stratification and disease monitoring.
Boreal Genomics
Boreal develops research tools and diagnostic tests based on the monitoring of tumor mutations from cell-free DNA in plasma.
ProterixBio
ProterixBio engages in developing innovative products to transform the management of chronic diseases.
Bioneb
Bioneb offers direct to consumer genetic testing companies in India.
Bionano Genomics
BioNano Genomics develops nanoscale imaging and analytic platforms designed to analyze DNA and other genome-related peptides and proteins.
Benitec Ltd
Benitec Biopharma is using patented ‘gene-silencing’ technology to develop drugs for chronic and life-threatening human diseases.
FOXO Technologies
FOXO Technologies is transforming the global longevity insurance industry with a next-generation underwriting protocol.
Trinity Biotech
Trinity Biotech has actively pursued the aim of becoming a leading player in the international diagnostics.
Jaguar Gene Therapy
Jaguar Gene Therapy is accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases.
Quanterix
Quanterix is a biotechnology company that develops ultrasensitive biomarker detection for healthcare.
Kuehnle Agrosystems
Kuehnle Agrosystems is involved in biotech research and development of plant-based systems for producing biologically active compounds.
KellBenx
Kellbenx focuses on the development of non-invasive prenatal diagnosis for specific genetic and other heritable disorders.
WaferGen Biosystems
WaferGen Biosystems is a life science company offering genomic tools for targeted resequencing, genotyping and expression analysis.
Seracare Life Sciences
SeraCare Life Sciences provides solutions that facilitate the R&D of human and animal diagnostics and therapeutics.
Solulink
SoluLink provides linking reagents, conjugation kits and services for life science research, diagnostics, and pharmaceutical markets.
Stellar Biotechnologies
Stellar Biotechnologies develops treatments for dermatological and anorectal diseases
SQI Diagnostics
SQI Diagnostics is a medical systems company that develops proprietary technologies in multiplexing, miniaturization and automation.
Desktop Genetics
Desktop Genetics is an international company to help researchers discover and treat the root genetic causes of human disease.
Denali Therapeutics
Denali Therapeutics is dedicated to defeating neurodegenerative diseases to deliver safe and effective medicines to patients and families.
Horizon Discovery
Horizon is a gene editing company that designs & engineers genetically-modified cells, applying them to advance human health.
HTG Molecular Diagnostics
HTG Molecular Diagnostics develops assays and reagent systems for gene expression analysis.
IntegenX
IntegenX designs, manufactures and markets automation systems facilitating reliable micro sample preparation and analysis.
IncellDx
IncellDx is a molecular diagnostics company focused on the detection and monitoring of life threatening viral diseases.
Immunovia
Immunovia is the center for translational cancer research in Lund, Sweden.
Immunexpress
Immunexpress Pty Ltd, a molecular diagnostics company, develops clinical assays for the management of immune disorders.
IMV Inc
IMV Inc applies its novel platform to the development of vaccines for cancer therapy, infectious diseases, and animal health.
Indee Labs
Indee Labs is unlocking gene-modified cell therapy for the masses with scalable hardware for gene delivery.
Genotyping
Genotyping brings precision medicine to consumers through genetic diagnosis using next-generation sequencing technology.
Grolltex, Inc.
Grolltex, the largest US producer of electronics grade graphene, is also designing and manufacturing graphene biosensors on plastic
Gemini Therapeutics
Gemini Therapeutics focuses on genetically-defined dry age-related macular degeneration (AMD) and associated rare genetic diseases.
Genapsys
Transform the human condition by building a scalable, affordable genomic sequencing ecosystem that will support research and diagnostics
Gen9
Gen9 provides gene synthesis technology that enables the high-throughput, automated production of DNA constructs.
Geron
Geron Corp. operates as a biopharmaceutical company which discovers and develops therapeutic products for cancer. Imetelstat, a novel,
Vero Biotech
Vero Biotech is a biopharmaceutical company that commercializes inhaled nitric oxide delivery systems for healthcare providers.
OPKO Health
Opko Health engages in the discovery and development of novel and proprietary technologies for pharmaceuticals and diagnostics.
Orgenesis
Orgenesis focuses on a novel therapeutic treatment for diabetes by correcting malfunctioning organs with new functional tissues.
Oxford Nanopore Technologies
Oxford Nanopore Technologies develops nanopore-based electronic systems for analyzing single molecules, including DNA, RNA, and proteins.
Origene Technologies
OriGene Technologies is a research tool company that provides a commercial collection of full-length human cDNAs.
Codagenix
Codagenix is a developer of live-attenuated viral vaccines intended to provide target antigens placed in an attenuated backbone virus.
Curetis
Curetis is a molecular diagnostic firm focused on the development and commercialization of tools for diagnosing severe infectious diseases.
Poxel
Poxel is a research integrated pharmaceutical company that develops products for metabolic diseases.
Porton Advanced Solutions
Porton Advanced Solutions provide end-to-end process development (PD), analytical development (AD), GMP manufacturing, and testing services.
Precision NanoSystem
Precision NanoSystem provides Neuro9Kit for the study of gene function in neurons and glia cells.
Personal Genome Diagnostics
Personal Genome Diagnostics develops a patient-specific analysis of the cancer genome by using advanced tools and technologies.
Purigen Biosystems
Purigen Biosystems' innovative products offer a truly transformative automated solution for DNA and RNA purification.
Current Advisors List
Board_member
2011-01-01
Board_member
Board_member
2011-05-01
Board_member
Board_member
2010-01-01
Board_member
Advisor
Board_member
Current Employees Featured
Nick Leschly CEO @ Bluebird Bio
CEO
2010-10-01
Ilya Shestopalov Director @ Bluebird Bio
Director
2020-10-01
Gerry Downey Senior Director @ Bluebird Bio
Senior Director
2021-05-01
Mark Lovell Associate Director Commercial Supply Chain Project Management @ Bluebird Bio
Associate Director Commercial Supply Chain Project Management
Philip Gregory Chief Scientific Officer @ Bluebird Bio
Chief Scientific Officer
2015-06-01
Amanda Kachinsky Senior Manager Global Sourcing @ Bluebird Bio
Senior Manager Global Sourcing
2019-09-01
Ilya Shestopalov Analytical Product Lead @ Bluebird Bio
Analytical Product Lead
2020-04-01
Tara O'Meara Vice President, Clinical Development Operations @ Bluebird Bio
Vice President, Clinical Development Operations
2016-06-01
Gina Consylman Chief Financial Officer @ Bluebird Bio
Chief Financial Officer
2021-08-01
David Davidson Chief Medical Officer @ Bluebird Bio
Chief Medical Officer
2012-02-01
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2014-07-01 | Pregenen | Pregenen acquired by Bluebird Bio | 139.9 M USD |
Investors List
California Institute for Regenerative Medicine
California Institute for Regenerative Medicine investment in Venture Round - Bluebird Bio
ARCH Venture Partners
ARCH Venture Partners investment in Series D - Bluebird Bio
Third Rock Ventures
Third Rock Ventures investment in Series D - Bluebird Bio
ArmaVir Partners
ArmaVir Partners investment in Series D - Bluebird Bio
Deerfield Partners
Deerfield Partners investment in Series D - Bluebird Bio
RA Capital Management
RA Capital Management investment in Series D - Bluebird Bio
Forbion Capital Partners
Forbion Capital Partners investment in Series D - Bluebird Bio
TVM Capital
TVM Capital investment in Series D - Bluebird Bio
Easton Capital
Easton Capital investment in Series C - Bluebird Bio
ARCH Venture Partners
ARCH Venture Partners investment in Series C - Bluebird Bio
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2017-12-07 | TC BioPharm | Bluebird Bio investment in Series B - TC BioPharm | 16 M USD |
Official Site Inspections
http://www.bluebirdbio.com Semrush global rank: 138.99 K Semrush visits lastest month: 636.91 K
- Host name: 20.49.97.21
- IP address: 20.49.97.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Bluebird Bio"
About Us - bluebird bio
Bluebird bio is pioneering gene therapy with purpose. We’re putting our care and expertise to work across a spectrum of rare disorders and cancers.See details»
Our Leadership Team - bluebird bio
For over 30 years, Mr. Vachon held a variety of leadership positions across the General Electric organization, and was a company officer beginning in 1999 and a member of GE’s Corporate …See details»
bluebird bio - Wikipedia
Bluebird bio, Inc., based in Somerville, Massachusetts, is a biotechnology company that develops gene therapies for severe genetic disorders. The company's only - in the European Union (EU) - approved drug is betibeglogene autotemcel (Zynteglo), which treats transfusion-dependent beta thalassemia (TDT), a rare genetic blood disorder, and has been approved for …See details»
investors & media - bluebird bio, Inc.
3 days ago Media@bluebirdbio.com; Investor Contacts. Investor@bluebirdbio.com; investors & media More events are coming soon. corporate profile. bluebird bio is pursuing curative gene …See details»
Bluebird Bio - Crunchbase Company Profile & Funding
Bluebird bio is a clinical-stage biotechnology company that develops gene therapies for severe genetic and rare diseases. The company's gene therapy procedures aim to genetically modify a patient's cells to fundamentally correct …See details»
corporate governance - bluebird bio, Inc.
Investor@bluebirdbio.com; corporate governance Corporate Governance Sub Menu. Highlights; Management; Board of Directors; Committee Composition; Materials for the 2023 Annual …See details»
Our History - bluebird bio
The all-employee auction has become an annual bluebird tradition. Each year, employees donate and bid on items to raise money for the charity of our choosing including the Ethan Zakes Foundation, Brian’s Hope, Sickle Cell Community …See details»
bluebird bio Announces Definitive Agreement to be Acquired by …
Feb 21, 2025 Investors may also obtain, at no charge, any such documents filed with or furnished to the SEC by (i) bluebird under the “Investors & Media” section of bluebird’s website …See details»
Working At bluebird bio: Company Overview and Culture - Zippia
Mar 14, 2024 www.bluebirdbio.com. Organization Type. Public. CEO. Nick Leschly. Social Media. bluebird bio is a clinical-stage biotechnology company that develops gene therapies for …See details»
bluebird bio Confirms Receipt of an Unsolicited Non-Binding …
Feb 21, 2025 SOMERVILLE, Mass.--(BUSINESS WIRE)--Mar. 28, 2025-- bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird”) today confirmed it has received an unsolicited non-binding …See details»
Our Focus: Helping People with Life-Altering Diseases - bluebird bio
We are focused on developing and delivering new therapies for severe genetic diseases that currently have limited or no treatment options. Our goal is to provide hope for a better life – …See details»
Bluebird Bio - Overview, News & Similar companies - ZoomInfo
Bluebird Bio contact info: Phone number: (339) 499-9300 Website: www.bluebirdbio.com What does Bluebird Bio do? Bluebird Bio was founded in 1992 and is headquartered in Cambridge, …See details»
bluebird bio Confirms Receipt of an Unsolicited Non-Binding
3 days ago Courtney O’Leary 978-621-7347 coleary@bluebirdbio.com. Media: Jess Rowlands 857-299-6103 jess.rowlands@bluebirdbio.com. Source: bluebird bio, Inc.See details»
Member Spotlight: Q&A with bluebird bio - MassBio - BCBN
Apr 16, 2024 About bluebird bio, Inc. bluebird bio is pursuing curative gene therapies to give patients and their families more bluebird days. Founded in 2010, bluebird has been setting the …See details»
Bluebird Bio - Craft
Oct 29, 2024 Bluebird Bio is a developer of gene therapies for severe genetic diseases. It works on ZYNTEGLO (betibeglogene autotemcel) program, gene therapy for people with β …See details»
Company: bluebird bio - CRISPR Medicine
Bluebird bio develops novel gene and cancer therapies. The company is developing its proprietary megaTAL gene-editing technology, although it still has to disclose its first pre-clinical candidate …See details»
bluebird bio to split into oncology and gene therapy specialists
4 days ago Character raises $93m for eye drugs, plus other financings. Recent financings in the biotech space include rounds for Character Bio, Tempero, Epicrispr, Hillstar Bio, and …See details»
Commitment to Patient Advocacy - bluebird bio
To receive updates and learn more about bluebird bio’s patient advocacy efforts, contact us at patientadvocacy@bluebirdbio.com. By providing your information, you agree to allow bluebird …See details»
bluebird bio Initiates Restructuring Intended to Optimize Cost ...
Sep 24, 2024 SOMERVILLE, Mass., September 24, 2024--Following a comprehensive review of its operations, bluebird bio, Inc. (Nasdaq: BLUE) today announced that the Company is …See details»
bluebird bio Presents Positive Long-Term Data On LYFGENIA ...
Dec 8, 2024 Investors: Courtney O’Leary, 978-621-7347 coleary@bluebirdbio.com Media: Jess Rowlands, 857-299-6103 jess.rowlands@bluebirdbio.com. More News From bluebird bio, Inc. …See details»